Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Reduced Inflammation

Research synthesisVery low evidenceModerate effect5 studies · 5 beneficial · 0 neutral · 0 harmful

Across 5 studies, all reported beneficial effects of Lactobacillus brevis SBC8803 on reduced inflammation, with the majority showing moderate effects. One randomized controlled trial in healthy adults found a statistically significant moderate effect on reducing exercise-induced inflammation. The evidence base is preliminary, consisting mostly of reviews and animal/mechanistic studies, with limited human data.

  • Studied populations: Healthy adults (from one RCT)

Caveats: Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Evidence base is small (only 5 studies) — conclusions should be considered preliminary. Only 1 of 5 studies reported a statistically significant finding, and most studies were reviews or in vitro/in vivo work, not direct human trials on this specific strain.

Generated May 12, 2026
8 of 8 papers
Back to top